Combining Signal Peptidase and Lipoprotein Processing Inhibitors Overcomes Ayr Resistance in Staphylococcus aureus.

Stone, Madeleine C; Mychack, Aaron; Coe, Kathryn A; Walker, Suzanne

Stone, Madeleine C; Mychack, Aaron; Coe, Kathryn A; Walker, Suzanne.

Afiliação

Stone MC; Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, Massachusetts, USA.
Mychack A; Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, Massachusetts, USA.
Coe KA; Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, Massachusetts, USA.
Walker S; Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, Massachusetts, USA.

Antimicrob Agents Chemother ; 67(5): e0011523, 2023 05 17.

Article em En | MEDLINE | ID: mdl-37097175

Assuntos

Daptomicina; Infecções Estafilocócicas; Humanos; Daptomicina/farmacologia; Staphylococcus aureus; Testes de Sensibilidade Microbiana; Antibacterianos/farmacologia; Antibacterianos/metabolismo; Infecções Estafilocócicas/microbiologia; Proteínas de Bactérias/metabolismo

Palavras-chave

antibiotic resistance; arylomycin; secretion; signal peptidase

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções Estafilocócicas / Daptomicina Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google